Cargando…

Positive impact of a faecal-based screening programme on colorectal cancer mortality risk

INTRODUCTION: The effectiveness of colorectal cancer (CRC) screening programs is directly related to participation and the number of interval CRCs. The objective was to analyse specific-mortality in a cohort of individuals invited to a CRC screening program according to type of CRC diagnosis (screen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibáñez-Sanz, Gemma, Milà, Núria, Vidal, Carmen, Rocamora, Judith, Moreno, Víctor, Sanz-Pamplona, Rebeca, Garcia, Montse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244848/ https://www.ncbi.nlm.nih.gov/pubmed/34191813 http://dx.doi.org/10.1371/journal.pone.0253369

Ejemplares similares

Diagnostic Performance of a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program According to Ambient Temperature and Humidity
por: Ibáñez-Sanz, Gemma, et al.
Publicado: (2022)

Future Prospects of Colorectal Cancer Screening: Characterizing Interval Cancers
por: Ibáñez-Sanz, Gemma, et al.
Publicado: (2021)

Altered pathways and colorectal cancer prognosis
por: Moreno, Victor, et al.
Publicado: (2015)

Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000–2012)
por: Binefa, Gemma, et al.
Publicado: (2016)

Correction: Positive impact of a faecal-based screening programme on colorectal cancer mortality risk
Publicado: (2021)

Text messaging as a tool to improve cancer screening programs (M-TICS Study): A randomized controlled trial protocol
por: Vives, Nuria, et al.
Publicado: (2021)

Short-term impact of the COVID-19 pandemic on a population-based screening program for colorectal cancer in Catalonia (Spain)
por: Vives, Nuria, et al.
Publicado: (2022)

Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients
por: Rodriguez-Alonso, Lorena, et al.
Publicado: (2018)

Evaluating the Potential of Polygenic Risk Score to Improve Colorectal Cancer Screening
por: Arnau-Collell, Coral, et al.
Publicado: (2022)

Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme
por: Clark, Gavin RC, et al.
Publicado: (2021)

Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
por: Obón-Santacana, Mireia, et al.
Publicado: (2021)

Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2019)

Colorectal cancer screening programme: is the French faecal immunological test (FIT) threshold optimal?
por: Pellat, Anna, et al.
Publicado: (2021)

Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme
por: Clark, Gavin RC, et al.
Publicado: (2022)

Implementation of a mailed faecal immunochemical test programme for colorectal cancer screening among Veterans
por: Deeds, Stefanie Ann, et al.
Publicado: (2022)

Analysis of Killer Immunoglobulin-Like Receptor Genes in Colorectal Cancer
por: Diaz-Peña, Roberto, et al.
Publicado: (2020)

Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme
por: Digby, Jayne, et al.
Publicado: (2023)

Potential Involvement of NSD1, KRT24 and ACACA in the Genetic Predisposition to Colorectal Cancer
por: Quintana, Isabel, et al.
Publicado: (2022)

Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
por: Arana-Arri, Eunate, et al.
Publicado: (2017)

Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia–Brussels colorectal cancer screening programme
por: Guo, Feng, et al.
Publicado: (2020)

Correction: Benefits of switching from guaiac-based faecal occult blood to faecal immunochemical testing: experience from the Wallonia–Brussels colorectal cancer screening programme
por: Guo, Feng, et al.
Publicado: (2021)

Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer.
por: Castiglione, G., et al.
Publicado: (1996)

Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study
por: Faivre, J, et al.
Publicado: (1999)

Faecal haemoglobin concentrations are associated with all-cause mortality and cause of death in colorectal cancer screening
por: Kaalby, Lasse, et al.
Publicado: (2023)

Faecal immunochemical test outside colorectal cancer screening?
por: Pin-Vieito, Noel, et al.
Publicado: (2021)

How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study
por: Bucchi, Lauro, et al.
Publicado: (2022)

Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme
por: Castiglione, G, et al.
Publicado: (2007)

Colorectal adenomas and diet: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme.
por: Little, J., et al.
Publicado: (1993)

Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing
por: van der Meulen, Miriam P., et al.
Publicado: (2022)

Use of the Analysis of the Volatile Faecal Metabolome in Screening for Colorectal Cancer
por: Batty, Claire A, et al.
Publicado: (2015)

Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the “interval cancer” perspective
por: Tran, Thuy Ngan, et al.
Publicado: (2022)

Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients
por: Kehlet, S. N., et al.
Publicado: (2016)

The Impact of a Six-Year Existing Screening Programme Using the Faecal Immunochemical Test in Flanders (Belgium) on Colorectal Cancer Incidence, Mortality and Survival: A Population-Based Study
por: Tran, Thuy Ngan, et al.
Publicado: (2023)

Imbalances in faecal and duodenal Bifidobacterium species composition in active and non-active coeliac disease
por: Collado, Maria Carmen, et al.
Publicado: (2008)

Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England
por: Murphy, Jacqueline, et al.
Publicado: (2017)

Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme
por: van Rossum, L G M, et al.
Publicado: (2009)

Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme
por: Peng, Szu-Min, et al.
Publicado: (2021)

Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening.
por: Castiglione, G., et al.
Publicado: (1992)

Sex differences in faecal occult blood test screening for colorectal cancer
por: Koskenvuo, L., et al.
Publicado: (2018)

Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
por: van der Vlugt, Manon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g2bolb3nc6d5s7ob5ffs8co8lt